OPIANT PHARMACEUTICALS, INC. company info

CIK 1385508
IRS Number 000000000
State of incorporation NV
Business address 201 SANTA MONICA BOULEVARD
SUITE 500
SANTA MONICA
CA
90401
Mail address 201 SANTA MONICA BOULEVARD
SUITE 500
SANTA MONICA
CA
90401

Short summary

OPIANT PHARMACEUTICALS, INC. is a California company, with head office located at 201 Santa Monica Boulevard Santa Monica, California 90401. In 2019 the company owned a total of 41.37 million USD worth of assets, including 40.23 million USD worth of current assets. The company amassed the most assets last year, totalling up to 41.37 million USD.

OPIANT PHARMACEUTICALS, INC. Income Statement

Name [in Millions USD]2004200520062007200820092010201120122013201420152016201720182019Trends
Research and development 0.510.280.462.412.814.868.48
Operating Expenses 9.4412.348.8111.308.4517.6417.4335.17
Operating Income (Loss) -9.44-12.34-8.81-11.30-6.90-7.74-1.88-21.19
Interest expense 0.060.550.160.03
Income Tax Expense (Benefit) 0000.800.05
Net income -0.03-0.03-0.020.03-2.02-9.44-12.42-9.18-11.48-7.04-7.81-2.61-21.20

OPIANT PHARMACEUTICALS, INC. Balance Sheet

Name [in Millions USD]2004200520062007200820092010201120122013201420152016201720182019Trends
Cash and cash equivalents 0.160.03-4.550.181.342.367.6011.2523.9223.22
Accounts Receivable, Net, Current 0034.3516.10
Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment 0.000.000.01
Intangible Assets, Net (Excluding Goodwill) 0.030.020.020.020.020.020.020.020.02
Total assets 0.050.660.241.412.469.8014.7928.8341.37
Current assets 0.030.640.221.392.439.7814.7828.7640.23
Accounts payable 1.27
Total current liabilities 0.661.502.464.093.134.338.769.40
Deferred Revenue, Noncurrent 1.005.802.082.392.100
Total liabilities 0.531.192.508.266.175.526.428.769.76
Common Stock, Value, Issued 0.120.150.180.000.000.000.000.000.00
Retained Earnings (Accumulated Deficit) -34.85-51.73-60.09-54.27-63.97-74.58-63.90

OPIANT PHARMACEUTICALS, INC. Cash Flow

Name [in Millions USD]2004200520062007200820092010201120122013201420152016201720182019Trends
Net income -0.03-0.03-0.020.03-2.02-9.44-12.42-9.18-11.48-7.04-7.81-2.61-21.20
Depreciation and amortization 0.000.000.010.00
Amortization of Intangible Assets 0.000.000.000.000.00
Depreciation and amortization 0.000.010.00
Accounts receivable 00.313.44-7.21
Accounts payable -0.10-0.05-0.010.160.11-0.172.07-1.92
Deferred revenue -0.75-4.80-0.040.32
Net Cash Provided by (Used in) Operating Activities -2.96-1.10-0.75-0.925.56-0.52
Payments to Acquire Property, Plant, and Equipment 00.010
Net Cash Provided by (Used in) Investing Activities 00-0.010
Net Cash Provided by (Used in) Investing Activities, Continuing Operations 0-0.010
Stock Issued During Period, Value, Share-based Compensation, Net of Forfeitures 1.366.12
Stock Issued During Period, Value, Share-based Compensation, Net of Forfeitures 1.366.12
Proceeds from Issuance of Common Stock 3.080.800.06017.15
Net Cash Provided by (Used in) Financing Activities 3.011.071.331.97-0.1717.02
Cash and Cash Equivalents, Period Increase (Decrease) 0.05-0.030.58-0.340.181.055.3916.50